Remove Framework Remove Invest Remove Southern California Remove Study
article thumbnail

Science37: Using Technology To Enable Remote, Clinical Trials, with Belinda Tan

socalTECH

The company is backed by more than $67M in funding from such investors as Glynn Capital Management, GV (formerly Google Ventures), Amgen Ventures, Lux Capital, Redmile Group, dRx Capital (a Qualcomm and Novartis joint investment company), and Sanofi Ventures. Belinda Tan: Most of our trials are Phase 2 and Phase 3 studies.

article thumbnail

Top 29 Startup Posts May 2010

SoCal CTO

friend of mine asked me to chat with a startup he’d invested in. First off the two prezis and then the case study material (i used ERPLY as inspiration). My angel investing strategy vs Joshua Schachter - Gabriel Weinberg , May 18, 2010 Joshua Schacter has a great AMA thread on HN about angel investing. Here’s why.

Startup 248
article thumbnail

Rustic Canyon Speaks out on GaiKai Exit, Changing Nature of VC, LA Tech & More

Both Sides of the Table

And no wonder, lately he and his partners are on a tear, investing out of their $200+ million VC fund. They recently exited their investment in Gaikai for $380 million while their rival OnLive (who had raised > $200 million) just went through bankruptcy. I’ve laid out my policy on seed investing pretty clearly and publicly.